Gilead Gains on Report Claiming Coronavirus Drug Working (1)
Gilead Sciences Inc. shares climbed in late trading Thursday after a report that a group of patients being treated in Chicago were “seeing rapid recoveries in fever and respiratory symptoms.” The report, from the medical news publication Stat, cited a video made by a researcher at the University of Chicago who is helping conduct a trial of Gilead’s drug remdesivir.
Can Coronavirus Be Treated? Gilead Drug to Undergo Human …
Feb 3, 2020The experimental drug has not yet been approved for use by any drug regulator in the world but is being used on patients battling the new virus in the absence of approved treatment options, Gilead …
Gilead Gains After Launching Phase 3 Coronavirus Drug …
Gilead Sciences – Get Report shares extended gains Thursday after the drugmaker said its nascent coronavirus treatment will undergo advance human testing in Asia. Gilead said that around 1,000 …
AHF Demands Gilead Drop Exclusive ‘Orphan Drug’ Claim on …
AHF is also urging the FDA to reconsider and rescind the orphan drug designation should Gilead fail to abandon its claim on remdesivir. Gilead earned over $18 billion in net profit in 2015; in …
Gilead’s Coronavirus Wonder-Drug Remdesivir Is Masking A …
When Gilead Science, Inc.’s (GILD) CEO Daniel O’Day released his March 28 open letter stating the firm’s new wonder-drug (the antiviral Remdesivir) could work against COVID-19, he had every …
Coronavirus Treatment: Gilead Suspends Compassionate-Use …
Related news Covid Report: Gilead Drug Shows Promise In Compassionate-Use Results. 4:31 PM ET Gilead Sciences drug remdesivir could gain authorization as a coronavirus treatment by mid-May …
AHF Demands Gilead Drop Exclusive ‘Orphan Drug’ Claim on …
AIDS Healthcare Foundation today is calling on Gilead Sciences Inc., one of the largest manufacturers of HIV/AIDS drugs, to immediately abandon its claim for “orphan drug” designation for remdesivir, an antiviral drug thought to have some promise in the treatment of COVID-19. The U.S. Food and Drug Administration approved Gilead’s application …
Trump’s FDA Grants Drug Company Exclusive Claim on …
Trump’s FDA Grants Drug Company Exclusive Claim on Promising COVID-19 Medication. … often working on issues regarding drug pricing. … “was given to remdesivir despite hefty support by the government for the development of the drug. Gilead Sciences’ remdesivir was developed with at least $79 million in U.S. government funding.” …
Gilead Surges After Offering Experimental Coronavirus Drug …
Gilead Surges After Offering Experimental Coronavirus Drug for Testing in China Gilead Sciences said its working with health authorities in China to test an experimental drug that could treat …
Covid Report: Gilead Nears Coronavirus Data In ‘Weeks’; J …
Last week, Gilead asked the FDA to rescind an orphan drug status for remdesivir in Covid-19 treatment. The biotech company said it believes it can still gain a speedy approval without the designation.
